Replies to post #421080 on Amarin Corp Plc (AMRN)

[Larrybirdlegend]

It is unprecedented for brand to maintain 57% market after generic entry, in fact, at jpm, holt even made mention the norm is 5-10%, but w api surplus plus bulk orders coming for added sales in Europe, row (&dont sleep on China); the company’s edge to outprice generic becomes even wider

Market share growth is coming, both by outplaying generic coupled w specter of branded generic , all told I fully expect market share in us to be greater than 57% of the pie and the US pie will be even bigger too

Throw in litigation side, undercutting generics, and surplus api discounts there’s a LOT happening that will hit the bottom line for the better

I’ve been accused of being an Uber bull, but I am certain science wins, the long, hard journey from du knock down to where it’s been, tide is turning and it’s a tsunami of green coming

I’ve loaded all dry powder and I’m ready for what’s to come